Register free for our breaking news email alerts with analysis and cutting edge commentary from our award winning team. Registration only takes a minute.

Rhenman Healthcare Equity L/S I1 EUR C

Ranked 1 out of 176 in - Long/Short Equity over 3 months
All calculations are in EUR unless stated

Objective

The objective of the Fund is to generate a consistent total return above the return generated by traditional investment vehicles through investments in long/short equity strategies.This fund invests in a global portfolio of equities, equity related derivatives, equity index derivatives and other equity related instruments, including but not limited to swaps, convertibles and ETFs, witch focus on the healthcare industry.

Showing fund performance in Peru View performance globally

Performance

Long/Short Equity over : 30/06/2018 - 30/09/2018

Total Return

Quarterly Performance

to 30/09/2018 Annual Q1 Q2 Q3 Q4
2018 5.0% 5.5% 10.6%
2017 34.5% 22.2% 0.2% 3.8% 5.8%
2016 -12.0% -23.1% 9.2% 8.4% -3.4%
2015 20.1% 27.3% 1.7% -18.7% 14.2%
2014 42.8% 6.3% 4.8% 10.6% 15.9%
2013 55.3% 20.8% 5.5% 15.3% 5.7%
2012 18.1% 11.1% 6.4% 4.0% -4.0%
2011 9.7% 0.5% 4.8% -8.5% 13.8%
2010 8.3% 12.6% -16.6% 3.3% 11.6%
2009 4.4% 7.7%

Month by Month Performance

Returns Vs Risk

Registered For Sale In

  1. Luxembourg
  2. Sweden

Fund Info

  • Launch date22/06/2009
  • Share Class size40Mn
  • Base currencyGBP
  • ISIN LU0417598108

Purchase Info

  • Min. initial investment250,000
  • Min. regular additional investment0

Charges

  • Annual management1.00%
  • Initial investment0.00%

Performance is for the period shown (month end to month end, bid/bid, gross income reinvested, calculated in the currency and currencies indicated).